Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 2(8): e772, 2007 Aug 22.
Artigo em Inglês | MEDLINE | ID: mdl-17712420

RESUMO

BACKGROUND: Mucopolysaccharidosis (MPS) IIIB (Sanfilippo Syndrome type B) is caused by a deficiency in the lysosomal enzyme N-acetyl-glucosaminidase (Naglu). Children with MPS IIIB develop disturbances of sleep, activity levels, coordination, vision, hearing, and mental functioning culminating in early death. The murine model of MPS IIIB demonstrates lysosomal distention in multiple tissues, a shortened life span, and behavioral changes. PRINCIPAL FINDINGS: To more thoroughly assess MPS IIIB in mice, alterations in circadian rhythm, activity level, motor function, vision, and hearing were tested. The suprachiasmatic nucleus (SCN) developed pathologic changes and locomotor analysis showed that MPS IIIB mice start their daily activity later and have a lower proportion of activity during the night than wild-type controls. Rotarod assessment of motor function revealed a progressive inability to coordinate movement in a rocking paradigm. Purkinje cell counts were significantly reduced in the MPS IIIB animals compared to age matched controls. By electroretinography (ERG), MPS IIIB mice had a progressive decrease in the amplitude of the dark-adapted b-wave response. Corresponding pathology revealed shortening of the outer segments, thinning of the outer nuclear layer, and inclusions in the retinal pigmented epithelium. Auditory-evoked brainstem responses (ABR) demonstrated progressive hearing deficits consistent with the observed loss of hair cells in the inner ear and histologic abnormalities in the middle ear. CONCLUSIONS/SIGNIFICANCE: The mouse model of MPS IIIB has several quantifiable phenotypic alterations and is similar to the human disease. These physiologic and histologic changes provide insights into the progression of this disease and will serve as important parameters when evaluating various therapies.


Assuntos
Comportamento Animal/fisiologia , Audição/fisiologia , Atividade Motora/fisiologia , Mucopolissacaridose III/fisiopatologia , Visão Ocular/fisiologia , Acetilglucosaminidase/deficiência , Animais , Cerebelo/citologia , Cerebelo/patologia , Criança , Ritmo Circadiano/fisiologia , Modelos Animais de Doenças , Orelha Interna/patologia , Orelha Média/patologia , Eletrorretinografia , Potenciais Evocados Auditivos/fisiologia , Feminino , Humanos , Lisossomos/enzimologia , Lisossomos/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Mucopolissacaridose III/enzimologia , Mucopolissacaridose III/patologia , Fenótipo , Retina/patologia , Teste de Desempenho do Rota-Rod , Núcleo Supraquiasmático/citologia , Núcleo Supraquiasmático/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA